[1] Lecoffre C, de Peretti C, Gabet A, et al. National Trends in Patients Hospitalized for Stroke and Stroke Mortality in France, 2008 to 2014. Stroke, 2017; 48, 2939−45. doi:  10.1161/STROKEAHA.117.017640
[2] Honghong Wang HZ. The summaries of ischemic cerebrovascular disease. Chin J Clin, 2011; 39, 7−10. (In Chinese)
[3] Hiltunen MO, Ylä-Herttuala S. DNA methylation, smooth muscle cells, and atherogenesis. Arterioscler Thromb Vasc Biol, 2003; 23, 1750−3.
[4] Tsaousi A, Mill C, George SJ. The Wnt pathways in vascular disease: lessons from vascular development. Curr Opin Lipidol, 2011; 22, 350−7. doi:  10.1097/MOL.0b013e32834aa701
[5] Register TC, Hruska KA, Divers J, et al. Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study. J Clin Endocrinol Metab, 2014; 99, 315−21. doi:  10.1210/jc.2013-3168
[6] Krishna SM, Seto SW, Jose RJ, et al. Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II-Induced Aortic Aneurysm and Atherosclerosis. Arterioscler Thromb Vasc Biol, 2017; 37, 553. doi:  10.1161/ATVBAHA.116.308723
[7] Sacco RL, Kasner SE, Broderick JP, et al. An Updated Definition of Stroke for the 21st Century A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2013; 44, 2064−89. doi:  10.1161/STR.0b013e318296aeca
[8] Liu ZH, Song-Bin QU. Estrogen and Ischemic Cerebrovascular Disease. Progress in Modern Biomedicine, 2012; 12, 195.
[9] Ying-Ying X U, Xiao-Yan Z, Zhao-Hong X, et al. Study of Relationship Between DNA Methylation of Estrogen Receptor-α Gene and Ischemic Stroke. Chinese Journal of Arteriosclerosis, 2015; 23, 1021−5. (In Chinese)
[10] Reppe S, Noer A, Grimholt RM, et al. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women. J Bone Miner Res, 2015; 30, 249−56. doi:  10.1002/jbmr.2342